CASP1 and neoplasm: Because TAMs can become lipid-accumulating and differentiate into a pro-tumorigenic phenotype as a result of activated Caspase-1, Caspase-1 inhibitors like NCX-4016, YVAD, and VAD can rewire TAMs into an anti-tumorigenic phenotype and stop tumor growth in vivo (159).